TABLE 1.

The demographic and baseline information of patients in the primary cohort.

Characteristics	With stable IAs n = 341	With rebleeding IAs n = 70	P value
Male, n (%)	129 (37.8%)	32 (45.7%)	0.219
Age, years, M ± SD	54.8 ± 10.4	54.0 ± 8.9	0.467
Comorbidities, n (%)
Hypertension	111 (32.6%)	39 (11.4%)	<0.001+
Dyslipidemia	28 (8.2%)	10 (14.3%)	0.110
Diabetes mellitus	11 (3.2%)	3 (4.3%)	0.656
Coronary heart disease	8 (2.3%)	3 (4.3%)	0.360
Ischemic stroke	10 (2.9%)	3 (4.3%)	0.556
Modified Fisher scale at admission, n (%)			0.517
I–II	121 (35.5%)	22 (31.4%)
III–IV	220 (64.5%)	48 (68.6%)
Hunt-Hess grade at admission, n (%)			0.829
I–II	219 (64.2%)	44 (62.9%)
III–V	122 (35.8%)	26 (37.1%)
Blood pressure
At admission, n (%)			0.578
<160/90 mmHg	114 (33.4%)	21 (30.0%)
>160/90 mmHg	227 (66.6%)	49 (70.0%)
Before rebleeding/surgery, n (%)			0.951
<140/80 mmHg	311 (91.2%)	64 (91.4%)
>140/80 mmHg	30 (8.8%)	6 (8.6%)
Treatment, n (%)
Dead before surgical intervention	7 (2.1%)	14 (20.0%)
Endovascular intervention	189 (55.4%)	36 (51.4%)
Microsurgical clipping	145 (42.5%)	20 (28.6%)
PHASES, m (IQR)	2 (0–4)	2 (1–5)	0.265
ELAPSS, m (IQR)	9 (5–14)	12.5 (7–15)	0.004+

⁺The parameter was significant. IAs, intracranial aneurysms.